raw materials – Page 8

Risk mitigation plan inadequate during risk assessment – FDA/EMA nitrosamine expectations

Addressing Inadequate Risk Mitigation Plans During Nitrosamine Risk Assessments The increasing scrutiny surrounding nitrosamines in pharmaceutical products necessitates robust risk assessment and mitigation strategies. When a risk mitigation plan is…

Improper segregation of materials during inventory reconciliation – preventing repeat storage deviations

Preventing Recurrent Deviations Through Proper Material Segregation in Inventory Reconciliation In pharmaceutical manufacturing, improper segregation of materials during inventory reconciliation can lead to significant deviations, impacting product quality and regulatory…

Supplier nitrosamine control weak during submission support – CAPA for nitrosamine findings

Addressing Weak Supplier Nitrosamine Control During Submission Support: A Comprehensive Playbook The increasing scrutiny of nitrosamine impurities in pharmaceuticals has led to heightened expectations for supplier control measures. Regulatory bodies…

Storage condition excursion during routine checks – GMP storage compliance requirements

Investigating Storage Condition Excursions During Routine Checks in GMP Compliance Within the pharmaceutical industry, the integrity of raw materials is paramount to ensure consistent product quality and compliance with Good…

Potential nitrosamine source identified during regulatory inspection – CAPA for nitrosamine findings

Actionable Guide for Managing Nitrosamine Risks Uncovered in Regulatory Inspections In the highly regulated landscape of pharmaceutical manufacturing, the identification of potential nitrosamine sources during regulatory inspections poses a significant…

Environmental monitoring gaps during routine checks – GMP storage compliance requirements

Identifying Environmental Monitoring Gaps during Routine Checks: A GMP Compliance Perspective In the pharmaceutical manufacturing landscape, maintaining rigorous environmental monitoring protocols is crucial for ensuring the quality and integrity of…

Regulatory query on nitrosamines during risk assessment – preventing product recall

Managing Regulatory Queries on Nitrosamines During Risk Assessment to Prevent Product Recall The detection of nitrosamines in pharmaceutical products has led to increased scrutiny from regulators such as the FDA,…

Improper segregation of materials during inspection walkthrough – product quality impact assessment

Assessing Product Quality Risks from Improper Material Segregation During Walkthrough Inspections In the world of pharmaceutical manufacturing, ensuring strict control of material handling is paramount to maintaining product quality and…

Analytical method sensitivity questioned during risk assessment – FDA/EMA nitrosamine expectations

Optimizing Analytical Method Sensitivity for Nitrosamine Risk Assessment Nitrosamines continue to be a point of sensitivity in the pharmaceutical sector, creating challenges in raw material management and quality control. As…

Storage condition excursion during inventory reconciliation – CAPA for warehouse failures

Investigation of Storage Condition Excursion During Inventory Reconciliation: A Practical Approach Storage condition excursions during inventory reconciliation can lead to significant quality concerns and regulatory implications in pharmaceutical manufacturing. This…

Nitrosamine risk assessment incomplete during supplier audit – FDA/EMA nitrosamine expectations

Nitrosamine Risk Assessment During Supplier Audits: Ensuring Completeness for Compliance Nitrosamine contamination has emerged as a critical quality issue, prompting heightened scrutiny from regulatory agencies such as the FDA and…

Storage condition excursion during deviation investigation – inspection defense documentation

Managing Storage Condition Excursions: A Comprehensive Approach for Deviation Investigations Storage condition excursions pose significant challenges within the pharmaceutical manufacturing landscape, impacting material integrity and product quality. These excursions, often…